Buchumschlag

Sex influences the progression of cephalic mechanical and light hypersensitivities in a mouse model of chronic migraine

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Marie Raquin, Yara Mrad, Mohamed A. Zkim, Radhouane Dallel, Isabelle Ranchon‐Cole, Cristina Alba‐Delgado
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	Headache: The Journal of Head and Face Pain
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Synergistic effect of combining dual enkephalinase inhibitor PL37 and sumatriptan in a preclinical model of migraine
von: Jeanne Rossignol, et al.
Veröffentlicht: (2024)

Youth with high‐frequency headaches due to migraine are more vulnerable to non‐cephalic pain complaints
von: Brooke L. Reidy, et al.
Veröffentlicht: (2025)

Glial activation in pain and emotional processing regions in the nitroglycerin mouse model of chronic migraine
von: Haley C. Cropper, et al.
Veröffentlicht: (2024)

The role of stress in the comorbidity of migraine and other chronic primary pain
von: Shi‐Jie Zhao, et al.
Veröffentlicht: (2025)

Effect of erenumab on the reversion from chronic migraine to episodic migraine in an Asian population: A post hoc analysis of the DRAGON study
von: Shuu‐Jiun Wang, et al.
Veröffentlicht: (2024)

Cognitive and emotional mechanisms underlying migraine quality of life
von: Shiri Shinan‐Altman, et al.
Veröffentlicht: (2026)

Rates and risk factors for migraine progression using multiple definitions of progression: Results of the longitudinal OVERCOME ( US ) study
von: Dawn C. Buse, et al.
Veröffentlicht: (2025)

Evaluating dual calcitonin gene‐related peptide antagonists for chronic migraine prevention
von: Kara S. Graves, et al.
Veröffentlicht: (2026)

Long‐term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication‐overuse headache
von: Andrew Blumenfeld, et al.
Veröffentlicht: (2024)

Eicosapentaenoic acid versus placebo as adjunctive therapy in chronic migraine: A randomized controlled trial
von: Ghader Mohammadnezhad, et al.
Veröffentlicht: (2024)

Waning light, waxing pain: The lunar cycle's association with migraine headache occurrence
von: Alexander Yoo, et al.
Veröffentlicht: (2025)

Persistence, effectiveness, and tolerability of anti‐calcitonin gene–related peptide monoclonal antibodies in patients with chronic migraine
von: Anna de Dios, et al.
Veröffentlicht: (2024)

Correction to “Smartphone‐delivered progressive muscle relaxation for the treatment of migraine in primary care: A randomized controlled trial”
Veröffentlicht: (2025)

Early effect of onabotulinumtoxinA on EEG ‐based functional connectivity in patients with chronic migraine: A pilot study
von: Matteo Conti, et al.
Veröffentlicht: (2024)

Changes in brainstem habituation during onabotulinumtoxinA treatment in chronic migraine: A prospective case–control study
von: Gerlinde Freimark, et al.
Veröffentlicht: (2025)

The safety and efficacy of onabotulinumtoxinA injections for children and adolescents with chronic migraine: A systematic review and meta‐analysis
von: Rebecca Lindsay, et al.
Veröffentlicht: (2024)

TRPM3 activation causes CGRP release in trigeminal neurons: Implications for migraine mechanisms
von: Philip V. Reducha, et al.
Veröffentlicht: (2025)

Mapping the migraine: Intracranial recording of cortical spreading depression in migraine with aura
von: Graham A. McLeod, et al.
Veröffentlicht: (2025)

Functional impairment of chronic migraine with medication overuse: Secondary analysis from the Medication Overuse Treatment Strategy ( MOTS ) trial
von: Samantha C. Shao, et al.
Veröffentlicht: (2024)

The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine
von: Rikki Mangrum, et al.
Veröffentlicht: (2024)

The effect of different exercise types on migraine frequency in individuals with migraine: A pilot study
von: Yunus Emre Meydanal, et al.
Veröffentlicht: (2025)

Letter to the Editor regarding “Persistence, effectiveness, and tolerability of anti‐calcitonin gene‐related peptide monoclonal antibodies in patients with chronic migraine”
von: Joaquín Borrás‐Blasco, et al.
Veröffentlicht: (2025)

Identifying cognitive‐affective mechanisms underlying disability in episodic migraine: Using the fear avoidance model to examine interactions
von: Janosch Fox, et al.
Veröffentlicht: (2025)

Sex‐specific differences in the relationship between AHA Life's Essential 8 factors and migraine disorders: A cross‐sectional evaluation in ELSA ‐Brasil study
von: Arão Belitardo de Oliveira, et al.
Veröffentlicht: (2025)

Sequential administration of peripheral nerve blocks and onabotulinumtoxinA for the treatment of chronic migraine and other headache disorders—A retrospective tolerability and safety study
von: Christopher C. Anderson, et al.
Veröffentlicht: (2024)

Remote electrical neuromodulation for reducing procedural pain in patients with chronic migraine receiving onabotulinumtoxinA injections: A randomized sham‐controlled study
von: Nan Cheng, et al.
Veröffentlicht: (2025)

Evaluating associations of migraine‐related vertigo
von: Nazia Karsan, et al.
Veröffentlicht: (2025)

Clinical factors associated with day‐to‐day peak pain severity in individuals with chronic migraine: A cohort study using daily prospective diary data
von: Marina Vives‐Mestres, et al.
Veröffentlicht: (2024)

Afterimage duration differs for migraine with or without aura
von: Florian Rimmele, et al.
Veröffentlicht: (2025)

Mechanisms for mindfulness in migraine: Does catastrophizing matter?
von: Rebecca Erwin Wells, et al.
Veröffentlicht: (2024)

Useful considerations for treating migraine in patients with autism
von: Sinifunanya E. Nwaobi
Veröffentlicht: (2026)

Lifestyle triggers of migraine: Sleep restriction and caffeine lower the threshold for migraine‐like responses in rats in a sex‐specific manner
von: Gabriel Camargo de Oliveira, et al.
Veröffentlicht: (2026)

No association between migraine and HLA alleles in a cohort of 13,210 individuals with migraine from the Danish Blood Donor Study
von: Inga Zalia Tummoszeit, et al.
Veröffentlicht: (2024)

Advancing toward precision migraine treatment: Predicting responses to preventive medications with machine learning models based on patient and migraine features
von: Chia‐Chun Chiang, et al.
Veröffentlicht: (2024)

Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials
von: Stephen D. Silberstein, et al.
Veröffentlicht: (2024)

Counting the cost: How migraine shapes lives and economies
von: Risako Shirane, et al.
Veröffentlicht: (2025)

Cardiovascular risk and triptan usage among patients with migraine
von: Ido Peles, et al.
Veröffentlicht: (2025)

Depression and anxiety are not associated with migraine outcomes in children and adolescents
von: Amy A. Gelfand
Veröffentlicht: (2024)

Integrating gepants into clinical practice for the acute treatment of migraine
von: Richard B. Lipton, et al.
Veröffentlicht: (2026)

Effectiveness and tolerability of galcanezumab for migraine prevention in patients ≥65 years: A real‐life multicenter study
von: Julia Peris‐Subiza, et al.
Veröffentlicht: (2025)